Aptevo Therapeutics Inc

NASDAQ:APVO  
7.06
-0.98 (-12.19%)
Earnings Announcements

Aptevo Therapeutics Reports Qtrly Loss Per Share of $1.43

Published: 11/12/2021 15:38 GMT
Aptevo Therapeutics Inc (APVO) - Aptevo Therapeutics Inc - Qtrly Loss per Share of $1.43.
Aptevo Therapeutics Inc - Restricted Cash of $1.3 Million As of September 30, 2021 is Expected to Be Released Over Next Twelve Months.
Further Company Coverage: Apvoo (reporting by Nandhini Srinivasan).
((nandhini.
Srinivasan@thomsonreuters.
Com;)).
Revenue is expected to be $3.4 Million
Adjusted EPS is expected to be -$1.30

Next Quarter Revenue Guidance is expected to be $3.65 Million
Next Quarter EPS Guidance is expected to be -$1.28

More details on our Analysts Page.